Top Posts

Achieving Value through Comprehensive Genomic Benefits Management (GBM)

Executive Summary, by InformedDNA   Precision medicine that harnesses advances in genomics holds enormous promise for impacting every aspect of a health plan’s business. When properly integrated, genomics enables more tailored care with the potential for tremendously improved outcomes–especially in specialties such as oncology and reproductive health. Genomics is a technically complex discipline with a …

Achieving Value through Comprehensive Genomic Benefits Management (GBM) Read More »

The Value of Pre-Test Genetic Counseling for Health Plans, Providers, and Patients

When patients hear from their healthcare providers that they may be good candidates for genetic testing, they typically have questions…or they may not even know what questions they should be asking in order to consent or not in an informed way. That is when genetic counseling should come into the picture. Pre-test genetic counseling, or …

The Value of Pre-Test Genetic Counseling for Health Plans, Providers, and Patients Read More »

Case Study: Post-Market Success for a New Gene Therapy

Patient populations affected with orphan diseases are rare and patient identification can be challenging and time-consuming. Our pharmaceutical client, while anticipating likely FDA approval for its new gene therapy, faced significant challenges identifying affected patients and encouraging the adoption of genetic testing into community physician practices. Learn how the InformedACCESSTM solution we deployed with our client resulted …

Case Study: Post-Market Success for a New Gene Therapy Read More »

3 Trends that Promise to Quietly Revolutionize Genomics in 2022

As we enter into 2022, health organizations should expect three industry-wide issues that have simmered on the back burner to begin rising to the forefront:  Equitable access to care; Stronger embrace of telehealth technologies; Advances in personalized medicine and how to know when they’re ready (or not) for prime time standard of care. Below is …

3 Trends that Promise to Quietly Revolutionize Genomics in 2022 Read More »

variants-of-uncertain-significance

Interpreting variants of uncertain significance (VUS) in larger hereditary cancer panels

As genetic testing panels get larger, strategies to manage the downstream implications of testing are important. In many scenarios, it is now easier for labs to perform multi-gene sequencing panels than it is to target specific individual genes. This situation has been used to call for less management of molecular genetic testing utilization, a particularly …

Interpreting variants of uncertain significance (VUS) in larger hereditary cancer panels Read More »

Case Study: Genetic Test Payment Integrity

Payment Integrity Edits Identify $26.5M in Inappropriate Genetic Testing Payments Driven by the rapid and ongoing increase in the number of genetic tests available on the market, genetic testing spending is projected to increase from $13B in 2020 to $29B by 2026. The growth and complexity of these tests create clinical and payment appropriateness challenges. …

Case Study: Genetic Test Payment Integrity Read More »

Solverwp- WordPress Theme and Plugin